marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-08-2024
Gilead Sciences Financial Ratios 2011-2024 | GILD
Annual Financial Ratios Gilead Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
16.2 | 22.7 | 14.7 | 576.1 | 15.1 | 16.6 | 24.7 | 7.1 | 6.7 | 13.2 | 40.5 | 23.3 | 13.4 |
P/S |
3.4 | 3.8 | 3.3 | 2.9 | 3.6 | 4.1 | 4.4 | 3.2 | 3.7 | 6.4 | 11.1 | 6.2 | 4.5 |
EPS |
4.5 | 3.7 | 5.0 | 0.1 | 4.2 | 4.2 | 3.5 | 10.1 | 12.4 | 8.0 | 2.0 | 1.7 | 1.8 |
EV (Enterprise Value) |
85.7 B | 98.9 B | 85.9 B | 64.9 B | 109 B | 115 B | 156 B | 125 B | 141 B | 168 B | 133 B | 70.2 B | 38.3 B |
EBITDA per Share |
6.38 | 6.1 | 8.16 | 3.47 | 4.48 | 7.42 | 11.8 | 14 | 15.9 | 10.7 | 3.19 | 2.83 | 2.64 |
EV/EBITDA |
8.3 | 9.4 | 16.6 | 10.4 | 9.1 | 6.1 | 5.6 | 9.9 | 26.5 | 15.6 | 8.7 | ||
PEG |
1.55 | 10.64 | 3.67 | -22.68 | 15.85 | 0.89 | -0.38 | -0.38 | 0.12 | 0.04 | 2.31 | -4.22 | 1.98 |
P/B |
1.5 | 1.7 | 1.3 | 1.0 | 3.6 | 4.2 | 5.6 | 4.9 | 6.4 | 10.1 | 10.6 | 6.3 | 5.5 |
P/CF |
11.5 | 11.5 | 8.0 | 8.7 | 9.8 | 12.1 | 10.1 | 6.0 | 6.2 | 13.0 | 42.8 | 21.6 | 10.7 |
ROE % |
24.81 | 21.62 | 29.55 | 0.68 | 23.78 | 25.33 | 22.57 | 69.73 | 94.74 | 76.50 | 26.18 | 27.13 | 40.83 |
ROA % |
9.12 | 7.27 | 9.16 | 0.18 | 8.74 | 8.57 | 6.58 | 23.70 | 34.93 | 34.91 | 13.67 | 12.20 | 16.20 |
ROCE % |
33.31 | 34.51 | 47.09 | 22.34 | 8.27 | 15.45 | 24.08 | 36.92 | 52.91 | 52.81 | 27.98 | 23.63 | 25.63 |
Current Ratio |
- | - | - | - | 3.1 | 3.4 | 2.7 | 2.2 | 2.5 | 3.1 | 1.1 | 1.4 | 5.5 |
DSO |
63.5 | 62.0 | 62.7 | 62.6 | 58.2 | 54.9 | 53.8 | 54.2 | 65.5 | 68.0 | 68.4 | 65.9 | 84.9 |
DIO |
92.5 | 100.8 | 91.3 | 104.0 | 72.0 | 61.2 | 66.9 | 135.9 | 178.1 | 133.6 | 262.5 | 257.7 | 238.8 |
DPO |
40.9 | 51.9 | 42.8 | 62.2 | 55.7 | 59.4 | 68.0 | 103.3 | 107.3 | 92.0 | 160.4 | 196.0 | 207.2 |
Operating Cycle |
156.0 | 162.8 | 154.0 | 166.6 | 130.2 | 116.1 | 120.7 | 190.2 | 243.6 | 201.5 | 330.9 | 323.6 | 323.7 |
Cash Conversion Cycle |
115.2 | 110.9 | 111.2 | 104.5 | 74.6 | 56.7 | 52.8 | 86.9 | 136.3 | 109.5 | 170.6 | 127.6 | 116.5 |
All numbers in USD currency
Quarterly Financial Ratios Gilead Sciences
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
1.29 | -3.34 | - | 1.75 | 0.84 | 0.81 | - | 1.43 | 0.91 | 0.02 | - | 2.06 | 1.21 | 1.38 | 1.24 | 0.29 | -2.66 | 1.23 | 2.13 | -0.92 | 1.48 | 1.55 | - | 1.62 | 1.4 | 1.18 | -2.96 | 2.08 | 2.35 | 2.07 | 2.36 | 2.52 | 2.62 | 2.58 | 3.26 | 3.14 | 3.05 | 2.91 | 2.32 | 1.8 | 2.39 | 1.45 | 0.52 | 0.51 | 0.51 | 0.47 | 0.5 | 0.45 | 0.47 | 0.29 | 0.44 | 0.48 | 0.48 | 0.41 |
EBITDA per Share |
- | -3.39 | - | 2.58 | 1.81 | 1.44 | - | 2.62 | 1.97 | 0.22 | - | 3.25 | 1.91 | 2.36 | - | 1.76 | -2.27 | 1.96 | - | -1.02 | 2.01 | 1.8 | - | 2.15 | 1.84 | 1.69 | - | 3.04 | 3.33 | 2.92 | - | 3.43 | 3.46 | 3.39 | - | 3.9 | 3.87 | 3.63 | - | 2.36 | 2.91 | 2 | - | 0.8 | 0.79 | 0.69 | - | 0.73 | 0.73 | 0.54 | - | 0.7 | 1.34 | 1.16 |
ROE % |
4.59 | 0.72 | 19.55 | 28.04 | 26.77 | 27.47 | 14.25 | 26.32 | 29.90 | 31.96 | 28.91 | 37.42 | 27.33 | 1.26 | 0.67 | 4.12 | -3.03 | 23.66 | 23.91 | 11.96 | 26.93 | 27.08 | 25.51 | 6.58 | 10.08 | 16.61 | 22.64 | 58.00 | 62.34 | 65.82 | 71.48 | 80.29 | 87.48 | 93.20 | 97.70 | 95.04 | 87.92 | 87.39 | 78.45 | 62.80 | 52.03 | 35.13 | 27.05 | 28.29 | 28.60 | 29.45 | 27.84 | 29.52 | 28.82 | 32.25 | 37.16 | 6.56 | 11.07 | 9.66 |
ROA % |
2.59 | 1.26 | 6.80 | 9.66 | 9.03 | 9.17 | 4.71 | 8.57 | 9.58 | 9.99 | 8.66 | 10.93 | 7.59 | 0.47 | 0.18 | 2.29 | -0.13 | 7.80 | 8.74 | 4.37 | 9.55 | 9.36 | 8.57 | 3.06 | 3.64 | 5.16 | 6.58 | 17.54 | 19.52 | 21.28 | 23.70 | 27.30 | 30.35 | 32.89 | 35.01 | 36.02 | 35.00 | 36.86 | 34.91 | 28.35 | 23.98 | 16.87 | 13.66 | 13.74 | 13.42 | 13.33 | 12.20 | 12.46 | 11.83 | 12.79 | 14.47 | 2.55 | 4.31 | 3.76 |
ROCE % |
13.33 | 6.76 | 27.79 | 41.26 | 42.98 | 45.13 | 24.50 | 42.39 | 46.81 | 48.17 | 44.53 | 55.52 | 48.62 | 20.84 | 7.80 | 1.26 | -16.27 | 10.91 | 14.18 | 26.44 | 45.25 | 45.12 | 32.99 | 51.64 | 58.02 | 68.17 | 57.89 | 81.18 | 85.82 | 89.04 | 71.94 | 102.08 | 108.92 | 115.19 | 89.41 | 111.97 | 104.40 | 102.70 | 70.89 | 80.98 | 68.52 | 50.07 | 29.26 | 40.48 | 41.59 | 42.82 | 31.18 | 46.08 | 49.76 | 53.47 | 43.37 | 14.89 | 15.09 | 13.38 |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
61.2 | 63.7 | - | 58.4 | 58.0 | 64.2 | - | 54.9 | 57.6 | 57.3 | - | 53.6 | 59.2 | 62.6 | 60.1 | 67.9 | 86.8 | 69.7 | 55.6 | 58.3 | 57.5 | 59.7 | 52.4 | 54.2 | 53.8 | 64.4 | 59.1 | 54.0 | 49.2 | 58.7 | 56.3 | 54.9 | 53.0 | 60.7 | 62.8 | 64.4 | 64.8 | 63.0 | 57.8 | 70.0 | 64.7 | 62.2 | 62.6 | 68.9 | 69.2 | 69.4 | 61.8 | 65.9 | 66.5 | 74.0 | 80.9 | 83.9 | 83.3 | - |
DIO |
114.6 | 107.0 | - | 96.1 | 101.5 | 100.4 | - | 96.7 | 94.2 | 99.3 | - | 128.6 | 116.6 | 116.1 | - | 134.6 | 144.3 | 122.7 | - | 81.3 | 84.1 | 82.8 | - | 68.4 | 62.1 | 73.6 | - | 70.8 | 64.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
34.2 | 34.5 | - | 35.2 | 39.5 | 49.9 | - | 38.6 | 36.3 | 41.3 | - | 44.5 | 38.7 | 47.4 | - | 67.5 | 72.4 | 73.3 | - | 62.9 | 65.1 | 71.7 | - | 66.4 | 60.3 | 73.1 | - | 72.0 | 66.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
175.8 | 170.7 | - | 154.4 | 159.5 | 164.6 | - | 151.6 | 151.8 | 156.7 | - | 182.2 | 175.8 | 178.7 | 60.1 | 202.5 | 231.1 | 192.3 | 55.6 | 139.6 | 141.6 | 142.4 | 52.4 | 122.7 | 115.8 | 138.0 | 59.1 | 124.8 | 114.1 | 58.7 | 56.3 | 54.9 | 53.0 | 60.7 | 62.8 | 64.4 | 64.8 | 63.0 | 57.8 | 70.0 | 64.7 | 62.2 | 62.6 | 68.9 | 69.2 | 69.4 | 61.8 | 65.9 | 66.5 | 74.0 | 80.9 | 83.9 | 83.3 | - |
Cash Conversion Cycle |
141.6 | 136.2 | - | 119.2 | 120.0 | 114.7 | - | 113.0 | 115.5 | 115.4 | - | 137.7 | 137.1 | 131.3 | 60.1 | 135.0 | 158.8 | 119.0 | 55.6 | 76.8 | 76.6 | 70.8 | 52.4 | 56.3 | 55.6 | 64.9 | 59.1 | 52.8 | 48.1 | 58.7 | 56.3 | 54.9 | 53.0 | 60.7 | 62.8 | 64.4 | 64.8 | 63.0 | 57.8 | 70.0 | 64.7 | 62.2 | 62.6 | 68.9 | 69.2 | 69.4 | 61.8 | 65.9 | 66.5 | 74.0 | 80.9 | 83.9 | 83.3 | - |
All numbers in USD currency